Auro Laboratories (530233.BO) Osake Kurssi

Auro Laboratories Ltd. engages in the manufacture of active pharmaceutical ingredients, intermediates and generic formulations. The company is headquartered in Mumbai, Maharashtra. The firm operates through the Pharmaceuticals segment. The company offers APIs under categories, such as antihistamine, muscle relaxant, diuretic, iron deficiency, anti-diabetic, anti-fungal, anti-ulcer, iodine supplement, anti-malaria, analgesics, antacids anti-inflammatory and others. Its products under intermediates include Glibenclamde Sulphonamide, Cis-bramo benzoate, Cls-Tosylate, 2-Ethoxy Benzoic Acid, 3,4,5, Trimethoxy Benzoic Acid and 5-Bromo Phthalide. The company also undertakes toll/custom manufacturing for APIs and Intermediates on contract basis. The firm has a presence in international markets with bulk of its production being exported to Southeast Asia, Middle East and several European Countries. Some of the countries it exports to are Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain and United Kingdom.